Filter Results:
(586)
Show Results For
- All HBS Web
(586)
- News (53)
- Research (441)
- Events (2)
- Multimedia (1)
- Faculty Publications (351)
Show Results For
- All HBS Web
(586)
- News (53)
- Research (441)
- Events (2)
- Multimedia (1)
- Faculty Publications (351)
- July 2021
- Teaching Note
The Carlyle Group: Carving Out Atotech
Teaching Note for HBS Case No. 321-153. On January 31, 2017, The Carlyle Group ("Carlyle") closed its $3.2 billion acquisition of Atotech, an international Specialty Chemicals and Equipment company. In Carlyle's Washington, DC headquarters, the US-based deal... View Details
- November 1989 (Revised August 1994)
- Supplement
Du Pont's Titanium Dioxide Business (C)
Provides students the opportunity to track industry evolution over time, to explore the role that signaling may play in such evolution, and to construct and validate industry scenarios. View Details
Ghemawat, Pankaj. "Du Pont's Titanium Dioxide Business (C)." Harvard Business School Supplement 390-115, November 1989. (Revised August 1994.)
- December 1996
- Case
Du Pont's Titanium Dioxide Business (F)
Provides students with the opportunity to track industry evolution over time, to explore the role that signaling may play in such evolution, and to construct and validate industry scenarios. View Details
Ghemawat, Pankaj. "Du Pont's Titanium Dioxide Business (F)." Harvard Business School Case 797-078, December 1996.
- November 1989 (Revised August 1994)
- Supplement
Du Pont's Titanium Dioxide Business (E)
Provides students the opportunity to track industry evolution over time, to explore the role that signaling may play in such evolution, and to construct and validate industry scenarios. View Details
Ghemawat, Pankaj. "Du Pont's Titanium Dioxide Business (E)." Harvard Business School Supplement 390-117, November 1989. (Revised August 1994.)
- February 2010
- Case
Amyris Biotechnologies: Commercializing Biofuel
By: Gary P. Pisano and Alison Berkley Wagonfeld
In 2009, Amyris Biotechnologies was building a plant in Brazil that used synthetic biology to convert sugarcane into both renewable fuels and renewable chemicals. The Amyris' marketing team was investigating the commercial interest for both types of products, while the... View Details
Keywords: Renewable Energy; Chemicals; Risk Management; Product Marketing; Product Development; Production; Environmental Sustainability; Commercialization; Biotechnology Industry; Brazil
Pisano, Gary P., and Alison Berkley Wagonfeld. "Amyris Biotechnologies: Commercializing Biofuel." Harvard Business School Case 610-031, February 2010.
- November 1989 (Revised August 1994)
- Supplement
Du Pont's Titanium Dioxide Business (B)
Provides students with the opportunity to track industry evolution over time, to explore the role that signaling may play in such evolution, and to construct and validate industry scenarios. View Details
Ghemawat, Pankaj. "Du Pont's Titanium Dioxide Business (B)." Harvard Business School Supplement 390-114, November 1989. (Revised August 1994.)
- November 1989 (Revised August 1994)
- Supplement
Du Pont's Titanium Dioxide Business (D)
Provides students the opportunity to track industry evolution over time, to explore the role that signaling may play in such evolution, and to construct and validate industry scenarios. View Details
Ghemawat, Pankaj. "Du Pont's Titanium Dioxide Business (D)." Harvard Business School Supplement 390-116, November 1989. (Revised August 1994.)
- September 1996 (Revised December 1997)
- Case
Cytec Industries' Spin-Off (A): Sink or Swim?
In the wake of market pressure to restructure, American Cyanamid spun off its poorly performing Chemicals Unit into a new publicly traded corporation, Cytec Industries. In addition to weak operations, Cytec inherited the bulk of Cyanamid's environmental and... View Details
Keywords: Organizational Change and Adaptation; Management Practices and Processes; Restructuring; Performance Improvement; Chemical Industry; United States
Wruck, Karen, and Sherry P. Roper. "Cytec Industries' Spin-Off (A): Sink or Swim?" Harvard Business School Case 897-053, September 1996. (Revised December 1997.)
- October 1994 (Revised January 1995)
- Case
Rhone-Poulenc (A) and (B) Condensed
Rhone-Poulenc, France's largest chemical firm, has achieved a major position in the United States as the result of an ambitious series of acquisitions. As it expanded in the United States from 1986 to 1990, Rhone-Poulenc management sought to take a "hands-off" approach... View Details
Keywords: Organizational Change and Adaptation; Multinational Firms and Management; Organizational Structure; Chemical Industry; France; United States
Rosenzweig, Philip M. "Rhone-Poulenc (A) and (B) Condensed." Harvard Business School Case 395-042, October 1994. (Revised January 1995.)
- September 1993
- Case
Rhone-Poulenc (B)
Rhone-Poulenc, France's largest chemical firm, has achieved a major position in the United States as the result of an ambitious series of acquisitions. As it expanded in the United States from 1986 to 1990, Rhone-Poulenc management sought to take a "hands-off" approach... View Details
Keywords: Organizational Change and Adaptation; Multinational Firms and Management; Organizational Structure; Chemical Industry; France; United States
Rosenzweig, Philip M. "Rhone-Poulenc (B)." Harvard Business School Case 394-041, September 1993.
- October 1990 (Revised April 1991)
- Case
RU 486 (A)
Describes the factors faced by Roussel UCLAF, a French drug company, in deciding whether and how to market a controversial new drug, RU 486, which is often called "the French abortion pill." Roussel's decision involved its relations with the French government, its... View Details
Keywords: Judgments; Ethics; Product Launch; Negotiation; Outcome or Result; Performance; Business and Government Relations; Health Industry; Health Industry; France; Germany; United States
Badaracco, Joseph L., Jr. "RU 486 (A)." Harvard Business School Case 391-050, October 1990. (Revised April 1991.)
- July 1997 (Revised April 1998)
- Case
Chase Manhattan Corporation: The Making of America's Largest Bank
By: Stuart C. Gilson and Cedric Escalle
Chase Bank and Chemical Bank intend to merge, producing the largest commercial bank in the United States, the fourth largest in the world. Projected financial benefits under the merger reflect significant planned reduction in operating costs, including 17,000 employee... View Details
Keywords: Commercial Banking; Profit; Corporate Strategy; Value Creation; Restructuring; Negotiation; Mergers and Acquisitions; Risk and Uncertainty; Resignation and Termination; Revenue; Banking Industry; United States
Gilson, Stuart C., and Cedric Escalle. "Chase Manhattan Corporation: The Making of America's Largest Bank." Harvard Business School Case 298-016, July 1997. (Revised April 1998.)
- September 2011
- Case
China Development Bank
By: Li Jin, Matthew Preble and Aldo Sesia
In May 2011, Chairman Chen Yuan of the China Development Bank (CDB) was thinking back on CDB's financing of a major project between Petroleo Brasileiro SA (Petrobras), Brazil's state-owned oil and gas producer and China Petroleum & Chemical Corporation (Sinopec), one... View Details
Keywords: International Finance; Emerging Markets; Energy Sources; Banks and Banking; Energy Industry; Brazil; China
Jin, Li, Matthew Preble, and Aldo Sesia. "China Development Bank." Harvard Business School Case 212-001, September 2011.
- September 1993
- Case
Rhone-Poulenc (A)
Rhone-Poulenc, France's largest chemical firm, with revenues of more than $7 billion in 1985, seeks to dramatically expand its presence in the United States. From 1986 to 1990, Rhone-Poulenc undertakes 18 separate acquisitions, ranging from small entrepreneurial firms... View Details
Rosenzweig, Philip M. "Rhone-Poulenc (A)." Harvard Business School Case 394-040, September 1993.
- 14 Jul 2020
- Research & Ideas
Restarting Under Uncertainty: Managerial Experiences from Around the World
decisions more quickly and reliably. Case 3: Preempt the threats Brazil Energy Biomass is an energy producer, generating steam from biomass and selling the energy to industrial clients in take-or-pay contracts. The company has two plants... View Details
Paul A. Gompers
Paul Gompers, Professor of Business Administration at the Harvard Business School, specializes in research on financial issues related to start-up, high growth, and newly public companies. Professor Gompers has an appointment in both the View Details
- September 1986 (Revised February 2007)
- Case
Solagen: Process Improvement in the Manufacture of Gelatin at Kodak
By: Dorothy A. Leonard and Brian DeLacey
Kodak must decide whether to make a major investment in a production facility designed around a new technique for producing the gelatin critical to so many film and paper products. Currently, gelatin making is an arcane art, unchanged in 150 years and heavily dependent... View Details
Keywords: Arts; Buildings and Facilities; Factories, Labs, and Plants; Experience and Expertise; Engineering; Investment; Time Management; Production; Research and Development; Semiconductor Industry
Leonard, Dorothy A., and Brian DeLacey. "Solagen: Process Improvement in the Manufacture of Gelatin at Kodak." Harvard Business School Case 687-020, September 1986. (Revised February 2007.)
- 2022
- Article
Missing Novelty in Drug Development
By: Joshua Krieger, Danielle Li and Dimitris Papanikolaou
We provide evidence that risk aversion leads pharmaceutical firms to underinvest in radical innovation. We introduce a new measure of drug novelty based on chemical similarity and show that firms face a risk-reward trade-off: novel drug candidates are less likely to... View Details
Keywords: Drug Development; Risk Aversion; Research and Development; Innovation and Invention; Investment; Pharmaceutical Industry
Krieger, Joshua, Danielle Li, and Dimitris Papanikolaou. "Missing Novelty in Drug Development." Review of Financial Studies 35, no. 2 (February 2022): 636–679.
- March 2001
- Article
Technological Acquisitions and the Innovation Performance of Acquiring Firms: A Longitudinal Study
By: Gautam Ahuja and Riitta Katila
This paper examines the impact of acquisitions on the subsequent innovation performance of acquiring firms in the chemicals industry. We distinguish between technological acquisitions, acquisitions in which technology is a component of the acquired firm's assets, and... View Details
Keywords: Innovation; Acquisitions; Knowledge; Strategy; Knowledge Acquisition; Acquisition; Innovation and Invention; Chemical Industry
Ahuja, Gautam, and Riitta Katila. "Technological Acquisitions and the Innovation Performance of Acquiring Firms: A Longitudinal Study." Strategic Management Journal 22, no. 3 (March 2001): 197–220.
- Article
The Evolution of Science-Based Business: Innovating How We Innovate
By: Gary P. Pisano
Science has long been connected to innovation and to business. As early as the late 19th century, chemical companies, realizing the commercial potential of science, created the first industrial research laboratories. During much of the 20th century, large-scale... View Details
Keywords: Entrepreneurship; Governance; Innovation and Management; Risk Management; Research and Development; Science-Based Business; Commercialization
Pisano, Gary P. "The Evolution of Science-Based Business: Innovating How We Innovate." Special Issue on Management Innovation—Essays in the Spirit of Alfred D. Chandler. Industrial and Corporate Change 19, no. 2 (April 2010): 465–482.